gamma-Vinyl GABA en es it fr

gamma-Vinyl GABA Brand names, gamma-Vinyl GABA Analogs

gamma-Vinyl GABA Brand Names Mixture

  • No information avaliable

gamma-Vinyl GABA Chemical_Formula


gamma-Vinyl GABA RX_link

No information avaliable

gamma-Vinyl GABA fda sheet

gamma-Vinyl GABA msds (material safety sheet)

gamma-Vinyl GABA Synthesis Reference

No information avaliable

gamma-Vinyl GABA Molecular Weight

129.157 g/mol

gamma-Vinyl GABA Melting Point

No information avaliable

gamma-Vinyl GABA H2O Solubility

55.1 mg/mL

gamma-Vinyl GABA State


gamma-Vinyl GABA LogP


gamma-Vinyl GABA Dosage Forms

Powder (500 mg sachets); Tablet (500 mg)

gamma-Vinyl GABA Indication

For use as an adjunctive treatment (with other drugs) in treatment resistant epilepsy, complex partial seizures, secondary generalized seizures, and for monotherapy use in infantile spasms in West syndrome.

gamma-Vinyl GABA Pharmacology

Vigabatrin, is an anticonvulsant chemically unrelated to other anticonvulsants. Vigabatrin inhibits the catabolism of GABA. It is an analog of GABA, but it is not a receptor agonist.

gamma-Vinyl GABA Absorption

Rapidly absorbed following oral administration. Food may slightly decrease the rate, but not the extent, of absorption.

gamma-Vinyl GABA side effects and Toxicity

No information avaliable

gamma-Vinyl GABA Patient Information

This medicine may reduce your ability to drive or operate machinery safely. Do not drive or operate machinery until you know how this medicine affects you and you are sure it won't affect your performance. Avoid stopping this medicine suddenly. The dose of this medicine should be gradually decreased over a period of two to four weeks. After months to years of taking this medication, damage to vision may occur. Regular eye examinations should be conducted and notify your doctor if any change in vision occurs.

gamma-Vinyl GABA Organisms Affected

Humans and other mammals